These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 26273194)

  • 1. Modeling the longitudinal latent effect of pregabalin on self-reported changes in sleep disturbances in outpatients with generalized anxiety disorder managed in routine clinical practice.
    Ruiz MA; Álvarez E; Carrasco JL; Olivares JM; Pérez M; Rejas J
    Drug Des Devel Ther; 2015; 9():4329-40. PubMed ID: 26273194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How well do randomized controlled trial data generalize to 'real-world' clinical practice settings? A comparison of two generalized anxiety disorder studies.
    Kasper S; Brasser M; Schweizer E; Lyndon G; Prieto R
    Eur Neuropsychopharmacol; 2014 Jan; 24(1):125-32. PubMed ID: 24290532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pregabalin on sleep in generalized anxiety disorder.
    Holsboer-Trachsler E; Prieto R
    Int J Neuropsychopharmacol; 2013 May; 16(4):925-36. PubMed ID: 23009881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K; Pollack MH; Feltner DE; Lydiard RB; Zimbroff DL; Bielski RJ; Tobias K; Brock JD; Zornberg GL; Pande AC
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling the cost-effectiveness of pregabalin versus usual care in daily practice in the treatment of refractory generalised anxiety disorder in Spain.
    De Salas-Cansado M; Álvarez E; Olivares JM; Carrasco JL; Ferro MB; Rejas J
    Soc Psychiatry Psychiatr Epidemiol; 2013 Jun; 48(6):985-96. PubMed ID: 23086587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and economic outcomes of adjunctive therapy with pregabalin or usual care in generalized anxiety disorder patients with partial response to selective serotonin reuptake inhibitors.
    Álvarez E; Olivares JM; Carrasco JL; López-Gómez V; Rejas J
    Ann Gen Psychiatry; 2015; 14(1):2. PubMed ID: 25632294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pregabalin for the treatment of patients with generalized anxiety disorder with inadequate treatment response to antidepressants and severe depressive symptoms.
    Olivares JM; Álvarez E; Carrasco JL; Pérez Páramo M; López-Gómez V
    Int Clin Psychopharmacol; 2015 Sep; 30(5):265-71. PubMed ID: 26111356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early improvement with pregabalin predicts endpoint response in patients with generalized anxiety disorder: an integrated and predictive data analysis.
    Montgomery SA; Lyndon G; Almas M; Whalen E; Prieto R
    Int Clin Psychopharmacol; 2017 Jan; 32(1):41-48. PubMed ID: 27583543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pregabalin long-term treatment and assessment of discontinuation in patients with generalized anxiety disorder.
    Kasper S; Iglesias-García C; Schweizer E; Wilson J; DuBrava S; Prieto R; Pitman VW; Knapp L
    Int J Neuropsychopharmacol; 2014 May; 17(5):685-95. PubMed ID: 24351233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.
    Lydiard RB; Rickels K; Herman B; Feltner DE
    Int J Neuropsychopharmacol; 2010 Mar; 13(2):229-41. PubMed ID: 19737439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pregabalin: dose-response relationship in generalized anxiety disorder.
    Boschen MJ
    Pharmacopsychiatry; 2012 Mar; 45(2):51-6. PubMed ID: 22086745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pregabalin versus sertraline in generalized anxiety disorder. An open label study.
    Cvjetkovic-Bosnjak M; Soldatovic-Stajic B; Babovic SS; Boskovic K; Jovicevic M
    Eur Rev Med Pharmacol Sci; 2015; 19(11):2120-4. PubMed ID: 26125277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term efficacy of pregabalin in generalized anxiety disorder.
    Feltner D; Wittchen HU; Kavoussi R; Brock J; Baldinetti F; Pande AC
    Int Clin Psychopharmacol; 2008 Jan; 23(1):18-28. PubMed ID: 18090504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
    Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
    Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Latent growth curve modeling for improvement of clinical symptoms on depression].
    Li LX; Zhang YB; Gao YH; Zhang M; Zhou S
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Aug; 34(8):832-5. PubMed ID: 24423774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pregabalin in generalized anxiety disorder: a placebo-controlled trial.
    Pande AC; Crockatt JG; Feltner DE; Janney CA; Smith WT; Weisler R; Londborg PD; Bielski RJ; Zimbroff DL; Davidson JR; Liu-Dumaw M
    Am J Psychiatry; 2003 Mar; 160(3):533-40. PubMed ID: 12611835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-response relationship of pregabalin in patients with generalized anxiety disorder. A pooled analysis of four placebo-controlled trials.
    Bech P
    Pharmacopsychiatry; 2007 Jul; 40(4):163-8. PubMed ID: 17694480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregabalin for the treatment of generalized anxiety disorder.
    Wensel TM; Powe KW; Cates ME
    Ann Pharmacother; 2012 Mar; 46(3):424-9. PubMed ID: 22395254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does early improvement predict endpoint response in patients with generalized anxiety disorder (GAD) treated with pregabalin or venlafaxine XR?
    Baldwin DS; Schweizer E; Xu Y; Lyndon G
    Eur Neuropsychopharmacol; 2012 Feb; 22(2):137-42. PubMed ID: 21839620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregabalin versus SSRIs and SNRIs in benzodiazepine-refractory outpatients with generalized anxiety disorder: a post hoc cost-effectiveness analysis in usual medical practice in Spain.
    De Salas-Cansado M; Olivares JM; Alvarez E; Carrasco JL; Barrueta A; Rejas J
    Clinicoecon Outcomes Res; 2012; 4():157-68. PubMed ID: 22745564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.